WALTHAM, Mass.--(BUSINESS WIRE)--OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a leading developer of biopharmaceutical compounds to treat cancer and certain ophthalmologic diseases, announced today that Dr. Richard Chin, its President and Chief Executive Officer, will present at the Cowen & Company 7th Annual Global Healthcare Conference at The Landmark London Hotel in London, England. Dr. Chin will present on Tuesday, November 7, 2006 at 8:00am local time / 3:00am ET.
